focus -WSS

focus

author：fashion 2025-09-06 03:15:12 - browse：752

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Belarusian journalist sentenced to 4 years in prison as crackdown continues

WSS

What to know about Virgin Galactic's 1st mission taking paying customers to space

Supreme Court rules employers must be more accommodating of religious observance

Illumina to lay off 10% of research and development team

Anavex keeps shifting the goalposts in its clinical trials

Drastic changes should bring profitability, startup health insurers say

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

entertainment

focus

explore

Duchenne breakthrough therapy leaves behind pioneering families

Supreme Court rules employers must be more accommodating of religious observance

Wildfire smoke exposes gaps in outdoor worker protections

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Heart attack and stroke risk calculators need revising

Why failed clinical trials don’t always spell doom for a new drug

How one medical school became remarkably diverse

The best solution to the drug shortages problem

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

leisure time

For Cytokinetics, FDA rejection of heart drug would help, not hinder

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

American woman, child freed after being kidnapped in Haiti last month

Anavex keeps shifting the goalposts in its clinical trials

GOP inquiry over gain

focus

leisure time

focus

Wikipedia